NIT
SUPN icon

NumerixS Investment Technologies’s Supernus Pharmaceuticals SUPN Stock Holding History

NumerixS Investment Technologies’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,600
Closed -$38K – 743
2020
Q2 		$38K Buy
+1,600
New +$35.4K 0.01% 851
2019
Q3 		– Sell
-2,600
Closed -$86K – 1215
2019
Q2 		$86K Sell
2,600
-15,242
-85% -$522K 0.02% 639
2019
Q1 		$612K Buy
17,842
+9,221
+107% +$343K 0.08% 298
2018
Q4 		$279K Buy
8,621
+1,420
+20% +$61.1K 0.09% 243
2018
Q3 		$360K Buy
7,201
+3,708
+106% +$183K 0.07% 399
2018
Q2 		$204K Buy
+3,493
New +$181K 0.05% 516
2018
Q1 		– Sell
-3,400
Closed -$135K – 1274
2017
Q4 		$135K Buy
+3,400
New +$134K 0.03% 586
2017
Q2 		– Sell
-200
Closed -$6K – 1339
2017
Q1 		$6K Sell
200
-4,700
-96% -$126K ﹤0.01% 1125
2016
Q4 		$124K Buy
+4,900
New +$109K 0.02% 812
2016
Q3 		– Sell
-17,891
Closed -$364K – 1305
2016
Q2 		$364K Sell
17,891
-49,600
-73% -$880K 0.05% 516
2016
Q1 		$1.03M Buy
67,491
+28,795
+74% +$376K 0.12% 236
2015
Q4 		$520K Sell
38,696
-32,009
-45% -$495K 0.06% 411
2015
Q3 		$992K Buy
+70,705
New +$1.31M 0.11% 227

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

NumerixS Investment Technologies's SUPN Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Supernus Pharmaceuticals (SUPN) in Q3 2020, closing a stake of 1,600 shares — an estimated $38K sold.

NumerixS Investment Technologies first reported a position in SUPN in Q3 2015 and held it in 13 quarters. The position peaked at $1.03M in Q1 2016. 209 funds tracked by Wall St. Rank hold SUPN as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Supernus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,600 Supernus Pharmaceuticals shares in Q3 2020, an estimated $38K.
  • NumerixS Investment Technologies first reported a position in Supernus Pharmaceuticals in Q3 2015 and held it in 13 quarters.
  • NumerixS Investment Technologies's Supernus Pharmaceuticals position peaked at $1.03M in Q1 2016.
  • 209 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.